Top Markets
Coin of the day
RayzeBio, Inc. Common Stock RayzeBio, Inc. Common Stock

RayzeBio, Inc. Common Stock

RYZB
株式のランク #5676
RayzeBio, Inc. is dedicated to creating radiopharmaceutical therapies (RPTs)... RayzeBio, Inc. is dedicated to creating radiopharmaceutical therapies (RPTs) for oncology applications. Its primary therapeutic candidate, RYZ101, is currently advancing through Phase 3 clinical trials for the management of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The company's innovative pipeline also features RYZ801, a distinct peptide engineered to deliver Actinium-225 (Ac225) by targeting GPC3, intended for treating hepatocellular carcinoma (HCC). Additionally, RayzeBio is developing RYZ811, a companion diagnostic imaging agent comprising a peptide binder, a chelator, and Gallium-68 (Ga68). Another active development program involves a novel proprietary small molecule designed to target CA9, delivering Ac225 for potential use against clear cell renal cell carcinoma (ccRCC). The firm was established in 2020 and is headquartered in San Diego, California.
株価
$62.49
最終同期: 2024-03-06
時価総額
$2.52B
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 RayzeBio, Inc. Common Stock (RYZB)

カテゴリー

RayzeBio, Inc. Common Stock(RYZB)の株価履歴
終値の最高値: $62.49 (2024-03-01)

終値の最安値: $20.99 (2023-09-01)
RayzeBio, Inc. Common Stock の株価履歴(2023 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2024 87.31%
2023 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$549.38 41.20%
US
$1.05K 47.75%
NL
$148.35 491.02%
US
$122.63 -12.65%
AU
$762.13 6.76%
CH